These emerging treatments, Tirzepatide , represent a significant advancement in treating metabolic dysfunction and conceivably other disorders. They all are classified as GLP-1 hormone stimulators, indicating they function to mimic the endogenous GLP-1 peptide, stimulating insulin release and suppressing hunger . Despite Semaglutide each one functi